Dermapharm Holding SE
SWB:DMP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dermapharm Holding SE
SWB:DMP
|
DE |
|
G
|
General Mills Inc
SWB:GRM
|
US |
|
S
|
Smartone Telecommunications Holdings Ltd
XMUN:SMA
|
HK |
|
D
|
Dermapharm Holding SE
DUS:DMP
|
DE |
|
Immunitybio Inc
F:26CA
|
US |
|
E
|
ExpreS2ion Biotech Holding AB
STO:EXPRS2
|
SE |
|
P
|
PennantPark Floating Rate Capital Ltd
F:22P
|
US |
|
Delta Dunia Makmur Tbk PT
IDX:DOID
|
ID |
|
Augros Cosmetic Packaging SA
PAR:AUGR
|
FR |
|
Hanmi Financial Corp
NASDAQ:HAFC
|
US |
|
Syntec Technology Co Ltd
TWSE:7750
|
TW |
|
Ardmore Shipping Corp
NYSE:ASC
|
BM |
|
P
|
Precious Shipping PCL
SET:PSL
|
TH |
|
M
|
Mosaic Co
XBER:02M
|
US |
Wall St Price Targets
DMP Price Targets Summary
Dermapharm Holding SE
According to Wall Street analysts, the average 1-year price target for DMP is 50.73 EUR with a low forecast of 44.2 EUR and a high forecast of 62.66 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DMP's stock price target?
Price Target
50.73
EUR
According to Wall Street analysts, the average 1-year price target for DMP is 50.73 EUR with a low forecast of 44.2 EUR and a high forecast of 62.66 EUR.
What is the Revenue forecast for Dermapharm Holding SE?
Projected CAGR
5%
Over the last 10 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 5 years is 5%.
What is the Gross Profit forecast for Dermapharm Holding SE?
Projected CAGR
4%
Over the last 10 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Dermapharm Holding SE?
Projected CAGR
6%
Over the last 10 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 6%.
What is the Pre-Tax Income forecast for Dermapharm Holding SE?
Projected CAGR
8%
Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 8%.
What is the Net Income forecast for Dermapharm Holding SE?
Projected CAGR
8%
Over the last 10 years, the compound annual growth rate for Net Income has been 26%. The projected CAGR for the next 3 years is 8%.
